Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR3A | P46098 | 4/20 | 0.60 |
| ▸ | ADRB1 | P08588 | 4/20 | 0.60 |
| ▸ | HTR3E | A5X5Y0 | 3/20 | 0.60 |
| ▸ | HTR3B | O95264 | 3/20 | 0.60 |
| ▸ | HTR3D | Q70Z44 | 3/20 | 0.60 |
| ▸ | HTR3C | Q8WXA8 | 3/20 | 0.60 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.60 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.60 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.60 |
| ▸ | HTR1A | P08908 | 2/20 | 0.60 |
| ▸ | HTR6 | P50406 | 2/20 | 0.60 |
| ▸ | USP2 | O75604 | 1/20 | 0.60 |
| ▸ | HTR2C | P28335 | 1/20 | 0.60 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.60 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.60 |
| ▸ | HTR7 | P34969 | 1/20 | 0.60 |
| ▸ | HTT | P42858 | 1/20 | 0.60 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9317924 | 0.82 | HTR3A (0.60) | HTR3AADRB1HTR3EHTR3BHTR3D | |
| SCHEMBL5237714 | 0.78 | HTR1A (0.51) | HTR3ACYP3A4HSD17B10ALDH1A1KDM4E | |
| SCHEMBL1729604 | 0.77 | HRH3 (0.45) | HTR3AADRB1HTR3EHTR3BHTR3D | |
| SCHEMBL6777260 | 0.77 | HTR3E (0.59) | HTR3AADRB1HTR3EHTR3BHTR3D | |
| SCHEMBL6771995 | 0.77 | PTPN11 (0.55) | HTR3AADRB1HTR3EHTR3BHTR3D | |
| Quipazine SCHEMBL322181 | 0.76 | KDM4E (1.00) | HTR3AADRB1HTR3EHTR3BHTR3D | |
| SCHEMBL6769794 | 0.75 | PTPN11 (0.44) | HTR3AALDH1A1KDM4ETDP1HTR1A | |
| SCHEMBL6769797 | 0.75 | PTPN11 (0.44) | HTR3AALDH1A1KDM4ETDP1HTR1A | |
| Quipazine SCHEMBL4062074 | 0.74 | KDM4E (0.97) | HTR3AADRB1HTR3EHTR3BHTR3D | |
| SCHEMBL239521 | 0.74 | P2RX7 (0.48) | HTR3AHTR1AMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6821967-B2 | AMINES SUCH AS 9-(4-(4-(BENZOTHIAZOL-2-YL)-PIPERAZIN-1-YL)-BUTYL)-9H-FLUORENE-9-CARBOXYLIC ACID (2,2,2-TRIFLUOROETHYL) AMIDE, USED AS MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN ANTAGONISTS, TO PREVENT ATHEROSCLEROSIS OR HYPERLIPEMIA | BOEHRINGER INGELHEIM PHARMA KG (DE) | 2004-11-23 | — | — | US | disclosed |
| US-20030166637-A1 | Substituted piperazine derivatives, the preparation thereofand their use as medicaments | BOEHRINGER INGELHEIM PHARMA GMBH & CO. KG (DE) | 2003-09-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030166637-A1 | Substituted piperazine derivatives, the preparation thereofand their use as medicaments | MTTP, CETP, CPT1A | HTR3A 2835/4885ADRB1 110/4885HTR3E 3268/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.